Search

everythinglearnresearchcommunity

for

Search:↓

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

Men using 5-alpha reductase inhibitors for prostate issues may have a slightly higher risk of blood clots.

Ruxolitinib can help regrow hair in severe alopecia areata.

A liver transplant patient with APECED had a rare VZV recurrence and pneumonia, treated successfully, but later died from other infections.

Terazosin and finasteride together cause no major issues.

Tazarotene gel is more effective for acne than tretinoin and works as well as adapalene.

Abrocitinib effectively treats severe alopecia areata with significant improvement and no side effects.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

The combination tablet of finasteride and doxazosin works the same as taking each drug separately.

JAK inhibitors show promise for treating various skin disorders effectively and safely.

Most patients successfully switched from the original adalimumab to a biosimilar with few reverting due to reduced effectiveness or side effects.

The formulated gel is a promising treatment for alopecia areata.

Oral tacrolimus helped a rheumatoid arthritis patient regrow hair lost due to alopecia areata.

Men over 66 taking medication for prostate enlargement have a higher risk of depression and self-harm, especially in the first 18 months of treatment.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

5α-reductase inhibitors may help with prostate cancer but could increase the risk of severe tumors, so careful use is advised.

Upadacitinib is effective and safe for treating severe alopecia areata in teens.

5α-Reductase inhibitors, like finasteride, can cause serious, persistent side effects not always listed in official drug information.

Deucravacitinib led to full hair regrowth in a severe alopecia areata patient.

Most pediatric cancer patients at Muhimbili National Hospital experienced adverse drug reactions during chemotherapy, highlighting the need for careful monitoring.

Antidepressants, 5α-reductase inhibitors, and isotretinoin can cause long-lasting sexual dysfunction.

Tranilast successfully treated a man's skin sarcoidosis when other treatments failed.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.